company background image
FERO

Ferozsons Laboratories KASE:FEROZ Stock Report

Last Price

PK₨290.70

Market Cap

PK₨10.5b

7D

6.0%

1Y

-28.3%

Updated

17 Aug, 2022

Data

Company Financials
FEROZ fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance4/6
Financial Health5/6
Dividends2/6

FEROZ Stock Overview

Ferozsons Laboratories Limited, together with its subsidiaries, imports, manufactures, and sells pharmaceuticals products and medical devices.

Ferozsons Laboratories Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Ferozsons Laboratories
Historical stock prices
Current Share PricePK₨290.70
52 Week HighPK₨419.00
52 Week LowPK₨240.90
Beta1.19
1 Month Change8.70%
3 Month Change10.51%
1 Year Change-28.32%
3 Year Change260.22%
5 Year Change10.63%
Change since IPO11,361.16%

Recent News & Updates

Shareholder Returns

FEROZPK PharmaceuticalsPK Market
7D6.0%2.3%2.7%
1Y-28.3%-22.8%-13.7%

Return vs Industry: FEROZ underperformed the PK Pharmaceuticals industry which returned -22.8% over the past year.

Return vs Market: FEROZ underperformed the PK Market which returned -13.7% over the past year.

Price Volatility

Is FEROZ's price volatile compared to industry and market?
FEROZ volatility
FEROZ Average Weekly Movement3.4%
Pharmaceuticals Industry Average Movement3.6%
Market Average Movement5.4%
10% most volatile stocks in PK Market8.0%
10% least volatile stocks in PK Market3.2%

Stable Share Price: FEROZ is less volatile than 75% of PK stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: FEROZ's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19541,252Osman Waheedhttps://www.ferozsons-labs.com

Ferozsons Laboratories Limited, together with its subsidiaries, imports, manufactures, and sells pharmaceuticals products and medical devices. The company offers products in various therapeutic areas of gastroenterology, hepatology, cardiology, oncology, dermatology, diabetes, immune disorders, pain management, pulmonology, urology, pediatric diseases, and other areas. It also provides medical devices in the areas of cardiology, electrophysiology, endoscopy, gastroenterology, pulmonology, urology, and peripheral interventions; and sells and distributes medicines and other related products.

Ferozsons Laboratories Limited Fundamentals Summary

How do Ferozsons Laboratories's earnings and revenue compare to its market cap?
FEROZ fundamental statistics
Market CapPK₨10.53b
Earnings (TTM)PK₨1.26b
Revenue (TTM)PK₨9.58b

8.3x

P/E Ratio

1.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
FEROZ income statement (TTM)
RevenuePK₨9.58b
Cost of RevenuePK₨5.41b
Gross ProfitPK₨4.17b
Other ExpensesPK₨2.91b
EarningsPK₨1.26b

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)34.92
Gross Margin43.56%
Net Profit Margin13.20%
Debt/Equity Ratio21.5%

How did FEROZ perform over the long term?

See historical performance and comparison

Dividends

3.4%

Current Dividend Yield

29%

Payout Ratio